Mounjaro Product Theater

Join Dr. L. Elizabeth Bernstein, Endocrinologist, Asheville Endocrinology Consultants in Asheville, NC and Clinical Assistant Professor of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC to learn about Mounjaro - the first and only glucose-dependent insulintropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults with type 2 diabetes (T2D). This presentation will include a review of clinical efficacy and safety results and how to get your adult patients with T2D started on Mounjaro.

Host or Publisher Ballad Health Diabetes Treatment Center